Huperzine A clinical trials

RENAISSANCE 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

This study is testing a new medicine, SPN-817, for adults who have focal onset seizures. We want to see if it helps reduce seizures and if it's safe. Some people will get the new medicine, and others will get a dummy medicine to compare the effects.